OOIR: Observatory of International Research

Papers

(The TQCC of Therapeutic Advances in Psychopharmacology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Analysis of the clinical characteristics of olanzapine-induced acute pancreatitis	55
Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness	32
Relationship between resilience and mental health among COVID-19 bereaved people: the mediating role of dual process coping	32
Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years’ experience at a UK high-secure hospital	32
History repeating: guidelines to address common problems in psychedelic science	29
Comment on: History repeating: guidelines to address common problems in psychedelic science	29
Disrupted emotion regulation and spontaneous neural activity in panic disorder: a resting-state fMRI study	29
The missing link? Pharmacists’ perspectives on discontinuation of long-term antidepressants: a qualitative study	28
The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial	23
Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study	21
Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit	20
Corrigendum to “Managing medical and psychiatric multimorbidity in older patients”	19
The efficacy of antipsychotics in the treatment of physical aggressive behavior in patients with dementia in nursing homes	17
Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry	16
Reasons for discontinuing and restarting lithium multiple times: a case-register study based on the South London and Maudsley NHS Foundation Trust Clinical Record Interactive Search system	16
Brugada syndrome: should we be screening patients before prescribing psychotropic medication?	16
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review	15
Risperidone-induced priapism: a case report and literature review	15
Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey	13
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia	12
Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?	12
Clinical outcomes following switching antipsychotic treatment due to market withdrawal: a retrospective naturalistic cohort study of pipotiazine palmitate injection (Piportil Depot) discontinuation, s	11
Reasons for admission to a general medical hospital for patients taking clozapine	11
Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors	11
Exploring the clinical factors affecting lithium dose and plasma level and the effect of brand	10

Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review	10
Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications	9
Will psilocybin lose its magic in the clinical setting?	9
Risperidone-induced neuroleptic malignant syndrome: a case report	8
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia	8
Corrigendum to ‘Comment on: History repeating: guidelines to address common problems in psychedelic science’	8